These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 39293087)
41. Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillation. Ageno W; Beyer-Westendorf J; Rubboli A Expert Opin Pharmacother; 2017 Sep; 18(13):1325-1332. PubMed ID: 28786696 [TBL] [Abstract][Full Text] [Related]
42. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry. Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155 [TBL] [Abstract][Full Text] [Related]
43. Dosing challenges with direct oral anticoagulants in the elderly: a retrospective analysis. Fava JP; Starr KM; Ratz D; Clemente JL Ther Adv Drug Saf; 2018 Aug; 9(8):405-414. PubMed ID: 30364869 [TBL] [Abstract][Full Text] [Related]
44. Direct oral anticoagulants and the risk of osteoporotic fractures in patients with non-valvular atrial fibrillation. Kuo LT; Lin SJ; Wu VC; Chang JJ; Chu PH; Lin YS Ther Adv Musculoskelet Dis; 2021; 13():1759720X211011374. PubMed ID: 33995605 [TBL] [Abstract][Full Text] [Related]
45. Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice. Ferri N; Colombo E; Tenconi M; Baldessin L; Corsini A Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745692 [TBL] [Abstract][Full Text] [Related]
46. Direct Oral Anticoagulants and Non-valvular Atrial Fibrillation: Compliance with Dose Level Guidelines in Patients Aged 80 Years and Over. Cavillon Decaestecker M; Ferret L; Decaestecker K; Gautier S; Verdun S; Tsogli ES Drugs Aging; 2021 Oct; 38(10):939-950. PubMed ID: 34486094 [TBL] [Abstract][Full Text] [Related]
47. Anticoagulation in Patients with Chronic Kidney Disease. Elenjickal EJ; Travlos CK; Marques P; Mavrakanas TA Am J Nephrol; 2024; 55(2):146-164. PubMed ID: 38035566 [TBL] [Abstract][Full Text] [Related]
48. Biopharmaceutics considerations for direct oral anticoagulants. de Andrade RP; Caldeira TG; Vasques BV; Morais Ruela AL; de Souza J Drug Dev Ind Pharm; 2021 Dec; 47(12):1881-1894. PubMed ID: 35377263 [TBL] [Abstract][Full Text] [Related]
49. Comparison of Effectiveness and Safety Among 3 Direct Oral Anticoagulants in Patients With Venous Thromboembolism - A Single-Center Retrospective Study. Ueno Y; Ikeda S; Motokawa T; Honda T; Kurobe M; Akashi R; Yonekura T; Yoshimuta T; Eguchi M; Kawano H; Maemura K Circ Rep; 2022 Nov; 4(11):533-541. PubMed ID: 36408357 [No Abstract] [Full Text] [Related]
50. The Use of Edoxaban in Patients with Nonvalvular Atrial Fibrillation and Venous Thromboembolism: A Pharmacist's Perspective. Stacy ZA; Richter SK Hosp Pharm; 2016 Jan; 51(1):26-34. PubMed ID: 38745713 [TBL] [Abstract][Full Text] [Related]
51. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know. Conway SE; Hwang AY; Ponte CD; Gums JG Pharmacotherapy; 2017 Feb; 37(2):236-248. PubMed ID: 27983747 [TBL] [Abstract][Full Text] [Related]
52. Use of direct-acting oral anticoagulants in solid organ transplantation: A systematic review. Bixby AL; Lichvar AB; Salerno D; Park JM Pharmacotherapy; 2021 Jan; 41(1):28-43. PubMed ID: 33155327 [TBL] [Abstract][Full Text] [Related]
53. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs). Hakeam HA; Al-Sanea N J Thromb Thrombolysis; 2017 Apr; 43(3):343-351. PubMed ID: 28050755 [TBL] [Abstract][Full Text] [Related]
54. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. Robertson L; Kesteven P; McCaslin JE Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010957. PubMed ID: 26636644 [TBL] [Abstract][Full Text] [Related]
55. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy. Finks SW; Trujillo TC; Dobesh PP Ann Pharmacother; 2016 Jun; 50(6):486-501. PubMed ID: 26917821 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of Direct Oral Anticoagulant Dosing and Monitoring in Two Geriatric Outpatient Clinics. Howerton MA; Suhrie EM; Gennari AS; Jones N; Ruby CM Sr Care Pharm; 2019 Mar; 34(3):192-205. PubMed ID: 31155026 [No Abstract] [Full Text] [Related]
57. Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma. Gouveia F; Bicker J; Santos J; Rocha M; Alves G; Falcão A; Fortuna A J Pharm Biomed Anal; 2020 Mar; 181():113109. PubMed ID: 31981828 [TBL] [Abstract][Full Text] [Related]
58. Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation. Rymer JA; Chiswell K; Young L; Chiu A; Liu L; Webb L; Carlisle M; Friedman D; Wang TY JAMA Netw Open; 2023 Jun; 6(6):e2317156. PubMed ID: 37285155 [TBL] [Abstract][Full Text] [Related]
59. Thromboembolic Events While Taking Direct Oral Anticoagulants: An Analysis of Post-market WHO Database Reports from 2012 to 2020. Mitrovic D; Emmens W; Naimi A; van der Mijle A; Veeger N; van Roon E; van den Bemt P Clin Drug Investig; 2022 Jul; 42(7):593-598. PubMed ID: 35675030 [TBL] [Abstract][Full Text] [Related]
60. Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population. von Vajna E; Alam R; So TY Cardiol Ther; 2016 Jun; 5(1):19-41. PubMed ID: 26739579 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]